Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Levin

Showing results (161-170 of 239) with videos related to

Pageof 24
Sort By:
Journal of Neurosurgery|December 1, 1984
Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytomaV A Levin, M S Edwards, P H Gutin, et al.
Cancer|March 1, 1995
The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumorsM A Weitzner, C A Meyers, C K Gelke, et al.
International Journal of Oncology|July 31, 1999
Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cellsY Saitoh, T Goto, V K Puduvalli, et al.
Journal of Neuro-Oncology|January 5, 2006
Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiformeV A Levin, P Giglio, V K Puduvalli, et al.
Cancer Research|August 1, 1985
Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beaglesV A Levin, D Byrd, B I Sikic, et al.
Journal of Neuro-Oncology|September 1, 1997
The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin)S E Kaba, A P Kyritsis, C Conrad, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1990
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportV A Levin, P Silver, J Hannigan, et al.
Pediatric Neurosurgery|October 1, 1996
Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapyM D Prados, W Wara, M S Edwards, et al.
Oncology Reports|February 19, 1999
Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profilingC H Rhee, S Ruan, S Chen, et al.
Neuro-Oncology|September 12, 2001
A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolutionE C Wooten, D Fults, R Duggirala, et al.
Pageof 24

Showing results (161-170 of 239) with videos related to

Sort By:
Pageof 24
Journal of Neurosurgery|December 1, 1984
Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytomaV A Levin, M S Edwards, P H Gutin, et al.
Cancer|March 1, 1995
The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumorsM A Weitzner, C A Meyers, C K Gelke, et al.
International Journal of Oncology|July 31, 1999
Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cellsY Saitoh, T Goto, V K Puduvalli, et al.
Journal of Neuro-Oncology|January 5, 2006
Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiformeV A Levin, P Giglio, V K Puduvalli, et al.
Cancer Research|August 1, 1985
Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beaglesV A Levin, D Byrd, B I Sikic, et al.
Journal of Neuro-Oncology|September 1, 1997
The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin)S E Kaba, A P Kyritsis, C Conrad, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1990
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportV A Levin, P Silver, J Hannigan, et al.
Pediatric Neurosurgery|October 1, 1996
Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapyM D Prados, W Wara, M S Edwards, et al.
Oncology Reports|February 19, 1999
Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profilingC H Rhee, S Ruan, S Chen, et al.
Neuro-Oncology|September 12, 2001
A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolutionE C Wooten, D Fults, R Duggirala, et al.
Pageof 24